11/20/2026 | Press release | Distributed by Public on 11/20/2026 15:06
Item 1.01 Entry into a Material Definitive Agreement.
On November 20, 2026, Advanced Biomed Inc., a Nevada Corporation (the "Company"), entered into a securities purchase agreement (the "Securities Purchase Agreement") with certain investors (the "Investors") relating to the issuance and sale of 320,000 shares of common stock (the "Purchased Shares"), par value $0.001 per share, of the Company (the "Common Stock"), at $0.35 per share for a total purchase price of $112,000 (the "Purchase Price").
The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Securities Purchase Agreements, which is filed as Exhibit 10.1 to this Current Report on Form 8-K.
This report does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
Item 3.02 Unregistered Sales of Equity Securities.
The information included in Item 1.01 of this Current Report is incorporated by reference into this Item 3.02 of this Current Report to the extent applicable. The Purchased Shares were issued in a private placement exempt from the registration requirements of the U.S. Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and Regulation S promulgated thereunder.